Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alena A. Zalutskaya"'
Publikováno v:
Journal of Biological Chemistry. 285:18270-18275
Growth plate abnormalities, associated with impaired hypertrophic chondrocyte apoptosis, are observed in humans and animals with abnormalities of vitamin D action and renal phosphate reabsorption. Low circulating phosphate levels impair hypertrophic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a32c9c585b90f01849d3a083dab81b7a
https://doi.org/10.1074/jbc.m109.098616
https://doi.org/10.1074/jbc.m109.098616
Publikováno v:
Journal of Cellular Biochemistry. 108:668-674
Phosphate is required for terminal differentiation of hypertrophic chondrocytes during postnatal growth plate maturation. In vitro models of chondrocyte differentiation demonstrate that 7mM phosphate, a concentration analogous to that of the late ges
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2995c1a658f288c039bdf91eb1172dd0
https://doi.org/10.1002/jcb.22302
https://doi.org/10.1002/jcb.22302
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 293:E259-E263
Urocortin 1 (UCN1) is a corticotropin-releasing factor (CRF)-like peptide whose role in stress is not well characterized. To study the physiological role of UCN1 in the response of the hypothalamic-pituitary-adrenal (HPA) axis to stress, we generated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23a1afd735a6b668f28d9c7f927b915
https://doi.org/10.1152/ajpendo.00616.2006
https://doi.org/10.1152/ajpendo.00616.2006
Autor:
Francesca Gori, Eva S. Liu, Byongsoo Timothy Chae, Marie B. Demay, Alena A. Zalutskaya, Eric D. Zhu
Publikováno v:
Endocrinology. 155(10)
Phosphate and parathyroid hormone related peptide (PTHrP) are required for normal growth plate maturation. Hypophosphatemia impairs hypertrophic chondrocyte apoptosis leading to rachitic expansion of the growth plate; however, the effect of phosphate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab256e77b4c1182651aafb1d9b40f28
https://pubmed.ncbi.nlm.nih.gov/25057796
https://pubmed.ncbi.nlm.nih.gov/25057796
Publikováno v:
Diabetologia. 47(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3ad61cad94e247b0bb6733dfdfd2ee
https://pubmed.ncbi.nlm.nih.gov/16132940
https://pubmed.ncbi.nlm.nih.gov/16132940
Autor:
Lim SM; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea., Schalm SS; Blueprint Medicines Corporation, Cambridge, MA, USA., Lee EJ; Department of Biomedical Science Institute, Graduated School of Medical Science, Brain Korea 21 FOUR Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea., Park S; JEUK Institute for Cancer Research, JEUK Co. Ltd., Seoul, Republic of Korea., Conti C; Blueprint Medicines Corporation, Cambridge, MA, USA., Millet YA; Blueprint Medicines Corporation, Cambridge, MA, USA., Woessner R; Blueprint Medicines Corporation, Cambridge, MA, USA., Zhang Z; Blueprint Medicines Corporation, Cambridge, MA, USA., Tavera-Mendoza LE; Blueprint Medicines Corporation, Cambridge, MA, USA., Stevison F; Blueprint Medicines Corporation, Cambridge, MA, USA., Albayya F; Blueprint Medicines Corporation, Cambridge, MA, USA., Dineen TA; Blueprint Medicines Corporation, Cambridge, MA, USA., Hsieh J; Blueprint Medicines Corporation, Cambridge, MA, USA., Oh SY; Department of Biomedical Science Institute, Graduated School of Medical Science, Brain Korea 21 FOUR Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea., Zalutskaya A; Blueprint Medicines Corporation, Cambridge, MA, USA., Rotow J; Dana-Farber Cancer Institute, Boston, MA, USA., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Lee DH; Department of Oncology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Republic of Korea., Yun MR; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Oct 21; Vol. 16, pp. 17588359241280689. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).
Autor:
Subbiah V; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hu MI; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Taylor MH; Developmental Cancer Therapeutics Laboratory, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA., Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany., Zhu VW; Department of Medicine, University of California Irvine, Orange, California, USA., Hadoux J; Department of Endocrine Oncology, Gustave Roussy, Villejuif, France., Curigliano G; Clinical Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Wirth L; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, Massachusetts, USA., Gainor JF; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, Massachusetts, USA., Alonso G; Early Drug Development Unit, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Adkins D; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Godbert Y; Nuclear Medicine and Thyroid Oncology Department, Bergonié Institute Cancer Center, Bordeaux, France., Ahn MJ; Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Zalutskaya A; Blueprint Medicines Corporation, Cambridge, Massachusetts, USA., Barata T; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Trask P; Genentech, Inc., South San Francisco, California, USA., Scalori A; F. Hoffmann-La Roche Ltd., Welwyn Garden City, United Kingdom., Bordogna W; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Heinzmann S; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Brose MS; Departments of Otorhinolaryngology; Head and Neck Surgery, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Thyroid : official journal of the American Thyroid Association [Thyroid] 2024 Jan; Vol. 34 (1), pp. 26-40.
Autor:
Subbiah V; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org., Cassier PA; Centre Léon Bérard, Lyon, France., Siena S; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano (La Statale) and Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Garralda E; Vall d'Hebron Institute of Oncology, Vall d'Hebron Hospital, Barcelona, Spain., Paz-Ares L; Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Ciberonc and Complutense University, Madrid, Spain., Garrido P; IRYCIS Hospital Universitario Ramón y Cajal, Ciberonc and Alcalá University, Madrid, Spain., Nadal E; Catalan Institute of Oncology, L'Hospitalet, Spain., Vuky J; Oregon Health & Science University, Portland, OR, USA., Lopes G; University of Miami Health System, Miami, FL, USA., Kalemkerian GP; University of Michigan, Ann Arbor, MI, USA., Bowles DW; University of Colorado, Aurora, CO, USA., Seetharam M; Mayo Clinic, Phoenix, AZ, USA., Chang J; Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen, China., Zhang H; Blueprint Medicines Corporation, Cambridge, MA, USA., Green J; Blueprint Medicines Corporation, Cambridge, MA, USA., Zalutskaya A; Blueprint Medicines Corporation, Cambridge, MA, USA., Schuler M; West German Cancer Center Essen, University Hospital Essen, Essen, Germany, and German Cancer Consortium (DKTK), Essen, Germany., Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou City, China., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
Publikováno v:
Nature medicine [Nat Med] 2022 Aug; Vol. 28 (8), pp. 1640-1645. Date of Electronic Publication: 2022 Aug 12.
Autor:
Eno MS; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Brubaker JD; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Campbell JE; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., De Savi C; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Guzi TJ; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Williams BD; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Wilson D; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Wilson K; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Brooijmans N; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Kim J; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Özen A; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Perola E; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Hsieh J; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Brown V; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Fetalvero K; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Garner A; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Zhang Z; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Stevison F; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Woessner R; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Singh J; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Timsit Y; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Kinkema C; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Medendorp C; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Lee C; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Albayya F; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Zalutskaya A; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Schalm S; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States., Dineen TA; Blueprint Medicines, 45 Sidney Street, Cambridge, Massachusetts 02139, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 Jul 28; Vol. 65 (14), pp. 9662-9677. Date of Electronic Publication: 2022 Jul 15.
Autor:
Kamoun W; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Swindell E; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Pien C; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Luus L; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Cain J; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Pham M; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Kandela I; Developmental Therapeutics Core Facility, Northwestern University, Evanston, IL 60208, USA., Huang ZR; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Tipparaju SK; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Koshkaryev A; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Askoxylakis V; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Kirpotin DB; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Bloom T; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Mino-Kenudson M; Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA., Marks JD; Departments of Anesthesia and Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA 94110, USA., Zalutskaya A; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA., Bshara W; Roswell Park Cancer Institute, Buffalo, NY 14203, USA., Morrison C; Roswell Park Cancer Institute, Buffalo, NY 14203, USA., Drummond DC; Merrimack Pharmaceuticals, Inc., Cambridge, MA 02142, USA.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2020 Oct 20; Vol. 12 (10). Date of Electronic Publication: 2020 Oct 20.